Accessibility StatementSkip Navigation -Â A total of 17 abstracts, including three accepted for presentation in the Cosmetic "Top Ten" Session, underscore Allergan Aesthetics' global industry leadership across multiple aesthetic categories -Â Oral abstract presentations include Phase 3 clinical study results for first-in-class botulinum neurotoxin serotype EÂ (trenibotulinumtoxinE) and results from a Phase 4 study evaluating natural outcomes and patient satisfaction in a diverse population following use of ...